infertility. Inability to achieve a pregnancy sterility
Conditions
Interventions
Intervention 1: for trial group|: 125 units Recombinant HCG
will be injected Subcutaneously from 8th day of their period for 7 days of mensuration period. Daily injection of 25 mg progesterone and da
Treatment - Drugs
for trial group|: 125 units Recombinant HCG
will be injected Subcutaneously from 8th day of their period for 7 days of mensuration period. Daily injection of 25 mg progesterone and daily usage of 80
Control group: Daily injection of projestron 25 mg and 800 milligrams progesterone suppository
Sponsors
Vice chancellor for research, Tehran University of medical sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria: Infertile women who were IVF candidate; infertile women who was recipient of Freezing embryo; Exclusion criteria: having uterus fibroma; having polyps bigger than 2 cm; Having Mullerian anomaly;
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chemical pregnancy. Timepoint: after four weekes. Method of measurement: B-HCG , miliunit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical pregnancy. Timepoint: two weeks after intervention. Method of measurement: transvaginal ultrasound and FHR. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mahshad Forati Kashani
Tehran University of Medical science
Outcome results
None listed